BioLife Sciences Inc.

BLFE

US09076L1035

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 15:17:38 01/05/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2023	BioLife Sciences, Inc. Announces the Release of the Prototype of the Its Copper-Infused Microfiber Towels for Second Quarter of the Fiscal Year	CI
2023	Biolife Sciences Inc. Announce Its Copper-Infused Wall Planters to Be Incorporated into Initial Copper Pot Product Line	CI

BioLife Sciences Inc. announced that it expects to receive $20 million in funding

June 31, 2022

BioLife Sciences Inc. announced that it will issue common shares at a price range between $0.05 to $0.50 per share for gross proceeds of $20,000,000 on June 1, 2022.

Latest news about BioLife Sciences Inc.

BioLife Sciences, Inc. Announces the Release of the Prototype of the Its Copper-Infused Microfiber Towels for Second Quarter of the Fiscal Year	23/02/23	CI
Biolife Sciences Inc. Announce Its Copper-Infused Wall Planters to Be Incorporated into Initial Copper Pot Product Line	08/02/23	CI
BioLife Sciences Inc. Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm	02/02/23	CI
Biolife Sciences Inc. Announces Slated Release of Its Copper-Infused Fabric Pot Prototype	22/11/22	CI
BioLife Sciences Inc. Expands Product Offerings in the Orthomolecular Medicine and Natural Health Markets with a Focus on Hemp Products	24/08/22	CI
Biolife Sciences Inc. Announces Launch of Hemp-Based Product Line	17/08/22	CI
BioLife Sciences Inc. Announces the Launch of BioLife Copper-Infused Microfiber Towels	25/07/22	CI
BioLife Sciences Inc. announced that it expects to receive $20 million in funding	31/05/22	CI
BioLife Sciences Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022	31/05/22	CI
Biolife Sciences Inc. Introduces Copper Infused Gardening Gloves to Its Newly Formed Horticultural and Agriculture Department	25/03/22	CI
Biolife Sciences Inc. Announces Expansion of Its Newly Formed Orthomolecular Medicine and Natural Health Products Department with Subsector Dedicated to Cannabidiol Sales and Products	01/03/22	CI
BioLife Sciences Inc. Announces the Launch of Their New Antimicrobial Copper-Infused Fabric Pot	16/02/22	CI
BioLife Sciences Inc. Launches a New Life Sciences Division	08/02/22	CI
BioLife Sciences Inc. entered into an agreement to acquire Healthbox, LLC for $ 0.87 million.	24/01/22	CI
BioLife Sciences Inc. Announces the Launch of New Copper Infused Face Masks	26/02/21	CI
Health Canada Testing Confirms Bio Life Hand Sanitizer by Bio Life Sciences Corp./10932540 Canada Inc. Contains Methanol, Which May Cause Serious Health Issues, Especially If Ingested	29/01/21	CI
BioLife Sciences Inc. Announces New Board of Directors	03/12/20	CI
BioLife Sciences Inc. announced that it expects to receive $4.5 million in funding from BeMotion Inc.	04/11/20	CI
Biolife Sciences Announces Agreement to Provide Aircraft Cleaning and Disinfecting Services for the Transportation & Travel Sector	02/11/20	CI
BioLife Sciences Announces the Availability of the FebriDx Ultra-Rapid, Health Canada Approved, Covid-19 Point of Care Test	26/10/20	CI
BioLife Sciences Inc. Announces the Launch of New Antimicrobial Air Filter Technology	15/10/20	CI
Biolife Sciences Inc. Offers Non-Contact Human Temperature Screening Technology	05/10/20	CI
BioLife Sciences Inc. Offers Intelligent, Touchless Vending Machines and Marketplaces	29/09/20	CI
BioLife Sciences Inc. Announces Distribution Agreement With BeMotion Inc	21/09/20	CI
Biolife Sciences Corp. entered into a binding agreement to acquire Rhino Novi, Inc. in a reverse merger transaction for CAD 37.5 million.	31/08/20	CI

BioLife Sciences Inc. is a commercialization accelerator, licensor, and disruptive technologies for the healthcare, beauty, and food and beverage industry sectors. The Companyâs core business develops, licenses and distributes antimicrobial products and disruptive technology. Its solutions include Antimicrobial Copper Air Filters, Copper-Infused Textiles and Copper Infused Fabric Pots. The Company's BioLife antimicrobial copper fabric filter acts as a layer of protection by trapping in bacteria and releasing clean air. BioLife Antimicrobial Copper-Infused Textiles kill viruses and bacteria on contact through preventative clothing and textiles designed to inhibit virus and bacteria reproduction and cross contamination before it starts. Its BioLife Copper Infused Fabric Pots provides plants a healthier home. The copper infusion allows the plants that grow in the pots with additional protections from harmful microbes which can harm plants.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BIOLIFE SCIENCES INC.	0.00%	4.83K
THERMO FISHER SCIENTIFIC	+11.73%	226B
DANAHER CORPORATION	+9.53%	188B
INTUITIVE SURGICAL, INC.	+14.63%	137B
BOSTON SCIENTIFIC CORPORATION	+27.47%	108B
SIEMENS HEALTHINEERS AG	+0.11%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+13.73%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	51B
AGILENT TECHNOLOGIES, INC.	+7.72%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+7.86%	38.07B

Other Advanced Medical Equipment & Technology